Operator: Good day, and thank you for standing by. Welcome to the UroGen Pharma's Q2 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Operator: Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2026 Corporate Update. My name is ...
Good morning, and welcome to the enGene Therapeutics call to discuss the non-muscle invasive bladder cancer market. [Operator Instructions] As a reminder, this call is being recorded, and a replay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results